Jaundice Phototherapy Calculator
Determine if neonatal jaundice requires phototherapy based on bilirubin, age, and risk factors.
Calculator
Adjust values & calculateBelow phototherapy threshold. Continue routine monitoring based on age and risk factors. Ensure adequate feeding and hydration. Recheck bilirubin per clinical protocol.
Formula
Phototherapy thresholds are determined from the AAP hour-specific nomogram, stratified by risk category: lower risk (>= 38 weeks, no risk factors), medium risk (>= 38 weeks + risk factors), and higher risk (35-37 6/7 weeks). Exchange transfusion thresholds are approximately 4-5 mg/dL above phototherapy thresholds. Bilirubin conversion: mg/dL x 17.1 = micromol/L.
Last reviewed: January 2026
Worked Examples
Example 1: Term Infant Approaching Phototherapy Threshold
Example 2: Late-Preterm Infant with Risk Factors
Background & Theory
The Jaundice Phototherapy Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Jaundice Phototherapy Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
Phototherapy threshold varies by age (hours), gestational age, and risk factors (AAP nomogram)
Phototherapy thresholds are determined from the AAP hour-specific nomogram, stratified by risk category: lower risk (>= 38 weeks, no risk factors), medium risk (>= 38 weeks + risk factors), and higher risk (35-37 6/7 weeks). Exchange transfusion thresholds are approximately 4-5 mg/dL above phototherapy thresholds. Bilirubin conversion: mg/dL x 17.1 = micromol/L.
Worked Examples
Example 1: Term Infant Approaching Phototherapy Threshold
Problem: A 48-hour-old term (39 weeks) infant has a total serum bilirubin of 16.5 mg/dL. The infant is exclusively breastfed, has no risk factors, and the direct antiglobulin test is negative.
Solution: Risk Category: Lower Risk (>= 38 weeks, no risk factors)\nAge: 48 hours\nPhototherapy threshold at 48h: ~18 mg/dL\nExchange threshold: ~25 mg/dL\nCurrent TSB: 16.5 mg/dL\nMargin to phototherapy: 1.5 mg/dL\nMargin to exchange: 8.5 mg/dL\nBilirubin in nmol/L: 16.5 x 17.1 = 282.2 nmol/L
Result: Below threshold (margin 1.5 mg/dL) | Recheck in 4-6 hours | Optimize breastfeeding
Example 2: Late-Preterm Infant with Risk Factors
Problem: A 36-hour-old late-preterm (36 weeks) infant has TSB of 13 mg/dL. The infant has ABO incompatibility with a positive DAT and appears slightly lethargic.
Solution: Risk Category: Higher Risk (35-37 6/7 weeks + risk factors)\nAge: 36 hours\nPhototherapy threshold at 36h: ~9.5 mg/dL\nExchange threshold: ~18.5 mg/dL\nCurrent TSB: 13.0 mg/dL\nExceeds phototherapy threshold by 3.5 mg/dL\nRisk factors: Isoimmune hemolytic disease, lethargy
Result: PHOTOTHERAPY INDICATED | 3.5 mg/dL above threshold | Start intensive phototherapy immediately
Frequently Asked Questions
What is neonatal jaundice and why does it occur?
Neonatal jaundice is a common condition affecting approximately 60 percent of term and 80 percent of preterm newborns, characterized by yellowish discoloration of the skin and sclera caused by elevated bilirubin levels. It occurs primarily because newborns have a higher rate of red blood cell turnover compared to adults (producing more bilirubin), combined with an immature hepatic conjugation system that cannot efficiently process and excrete bilirubin. Fetal hemoglobin has a shorter lifespan (70-90 days vs 120 days for adult hemoglobin), increasing bilirubin production. Additionally, the neonatal liver has limited activity of the enzyme uridine diphosphate glucuronosyltransferase (UGT1A1) responsible for conjugating bilirubin. Most neonatal jaundice is physiological and self-limiting, but pathological hyperbilirubinemia can cause bilirubin-induced neurological dysfunction.
What is the difference between physiological and pathological jaundice in newborns?
Physiological jaundice is a normal transitional process that appears after the first 24 hours of life, peaks between days 3 and 5 in term infants (days 5-7 in preterm infants), and resolves within 1 to 2 weeks. Total serum bilirubin (TSB) typically does not exceed 12-13 mg/dL in term infants. Pathological jaundice, by contrast, is characterized by one or more of the following features: onset within the first 24 hours of life, bilirubin rising faster than 5 mg/dL per day or 0.2 mg/dL per hour, TSB exceeding age-specific thresholds on the Bhutani nomogram, direct (conjugated) bilirubin greater than 1 mg/dL, or jaundice persisting beyond 2 weeks in a term infant. Pathological jaundice requires prompt investigation for underlying causes including hemolytic disease, infection, metabolic disorders, or biliary obstruction.
How does phototherapy work to reduce bilirubin levels?
Phototherapy works through three photochemical mechanisms that convert unconjugated bilirubin in the skin into water-soluble isomers that can be excreted without hepatic conjugation. The primary mechanism is structural isomerization (lumirubin formation), which converts bilirubin (4Z,15Z) to lumirubin, an irreversible structural isomer that is rapidly excreted in bile without conjugation. The second mechanism is configurational (geometric) isomerization, converting 4Z,15Z-bilirubin to the 4Z,15E isomer, which is more water-soluble but can revert to the native form. The third mechanism is photo-oxidation, which breaks bilirubin into small, water-soluble fragments. Blue-green light in the 460-490 nanometer wavelength range is most effective because it matches the absorption peak of bilirubin. Effective phototherapy requires maximum skin surface exposure and adequate light irradiance (at least 30 microwatts per square centimeter per nanometer).
When is exchange transfusion indicated for neonatal jaundice?
Exchange transfusion is indicated when total serum bilirubin reaches levels that pose an imminent risk of bilirubin-induced neurological dysfunction, typically at levels 4 to 5 mg/dL above the phototherapy threshold or when there are clinical signs of acute bilirubin encephalopathy regardless of the TSB level. For term infants with no risk factors, exchange transfusion is generally considered at TSB levels approaching 25 mg/dL, while for infants with risk factors or lower gestational age, lower thresholds apply. The procedure involves removing the infant's blood in small aliquots (5-10 mL/kg) and replacing it with compatible donor blood, typically exchanging twice the infant's blood volume (approximately 160-180 mL/kg). A double-volume exchange removes approximately 85 percent of circulating bilirubin. Exchange transfusion carries significant risks including electrolyte disturbances, thrombocytopenia, and cardiac complications.
How should bilirubin levels be monitored during phototherapy?
During phototherapy, total serum bilirubin (TSB) should be monitored regularly to assess treatment response and guide clinical decisions. After initiating intensive phototherapy, the first repeat TSB should be obtained within 4 to 6 hours to confirm that bilirubin is declining. A decrease of 1 to 2 mg/dL within the first 4 to 6 hours indicates an adequate response. Subsequent TSB measurements should be performed every 6 to 12 hours, depending on the severity and trajectory of bilirubin levels. Phototherapy can typically be discontinued when TSB falls to a level at least 2 to 3 mg/dL below the phototherapy threshold for the infant's age. A rebound TSB should be checked 12 to 24 hours after discontinuation because bilirubin levels may rebound, particularly in infants with ongoing hemolysis. Transcutaneous bilirubin measurements are unreliable during and immediately after phototherapy due to skin bleaching.
What role does breastfeeding play in neonatal jaundice?
Breastfeeding is associated with neonatal jaundice through two distinct mechanisms. Breastfeeding jaundice (also called breastfeeding failure jaundice) occurs in the first week of life when inadequate breastmilk intake leads to dehydration, reduced stool output, and increased enterohepatic circulation of bilirubin. This is primarily a feeding problem, not a breastmilk problem, and the solution is to increase breastfeeding frequency (8-12 times per day) and supplement with expressed breastmilk or formula if weight loss exceeds 7 to 10 percent. Breast milk jaundice is a separate phenomenon occurring after the first week, caused by substances in mature breast milk (possibly beta-glucuronidase and epidermal growth factor) that increase intestinal reabsorption of bilirubin. Breast milk jaundice is benign and can persist for 4 to 12 weeks. The AAP explicitly recommends against discontinuing breastfeeding in jaundiced newborns.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy